Yao Lu

Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma

Yudong Su, Bingying Luo, Yao Lu et al. · Clinical Cancer Research · 2021 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma

Rashmi Chugh, Karla V. Ballman, Lee J. Helman et al. · Cancer · 2020 · 46 citations · Full text

Medicine, Oncology, Pharmacology +13

Inhibitory effect of voluntary running wheel exercise on the growth of human pancreatic Panc-1 and prostate PC-3 xenograft tumors in immunodeficient mice

Allan H. Conney, George C. Wagner, Yao Lu et al. · Oncology Reports · 2008 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +10

The Impact of Cloud Computing and AI on Industry Dynamics and Competition

Yao Lu, Gordon M. Phillips, Yang Jia · SSRN Electronic Journal · 2023 · 25 citations · Full text

Computing, Cloud Computing, Economics +14

The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide

Roy E. Strowd, Inas Abuali, Xiaobu Ye et al. · Journal of Neuro-Oncology · 2016 · 18 citations · Full text

Medicine, Neurosurgery, Oncology +10